🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, cross-over, fixed-sequence study. All subjects will ...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02473627
Treatments Being Tested
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
The purpose of this study is to evaluate the effect of 26489112 on the phar...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01147887
Treatments Being Tested
This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequen...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2021-11-02
Trial ID
NCT05097716
Treatments Being Tested
This is a single-centre, open-label, fixed-sequence trial to evaluate the i...
Status
Completed
Location
CTC Clinical Trial Consultants AB
Start Date
2023-03-29
Trial ID
NCT05830799
Treatments Being Tested
This study has two parts. Part 1 will evaluate how pexidartinib affects th...
Status
Completed
Location
HonorHealth
Start Date
2018-02-26
Trial ID
NCT03291288
Treatments Being Tested
Human safety studies will be carried out to test whether red clover botanic...
Status
Completed
Location
University of Illinois at Chicago
Start Date
2019-04-01
Trial ID
NCT03948243
Treatments Being Tested
Protocol title: Effect of acute alcohol consumption on the activity of majo...
Status
Completed
Location
Department of Pharmacology I, University Hospital Cologne
Start Date
2015-06
Trial ID
NCT02515526
Type 2 diabetes (T2D) could modulate CYP450 activities involved in drug-met...
Status
Completed
Location
Centre hospitalier de l'Université de Montréal (CHUM)
Start Date
2015-04
Trial ID
NCT02291666
Treatments Being Tested